Acurx Pharmaceuticals LLC

ACXP | $1.965 -2.24% -2.29% 52K

(0.0% 1d) (-5.3% 1m) (-38.7% 1y) (0.0% 2d) (0.0% 3d) (-7.0% 7d) (-45.01% volume)
Earnings Calendar: 2024-03-18
Market Cap: $ 30,962,705
https://www.acurxpharma.com
Sec Filling | Patents | 3 employees

Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections. The Company's approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme and its R&D pipeline includes early stage antibiotic candidates that target other Gram-positive bacteria, including Methicillin-Resistant Staphylococcus aureus (MRSA), Vancomycin-Resistant Enterococcus (VRE) and Penicillin-Resistant Streptococcus pneumoniae (PRSP).

injection

add to watch list Paper trade email alert is off

Quantum-Si Incorporated - Class A

QSI | $1.625 3.5% 3.38% 380K

Professional, Scientific, and T...

(0.0% 1d) (-9.0% 1m) (-1.8% 1y) (0.0% 2d) (0.0% 3d) (5.9% 7d) (-47.64% volume)
Earnings Calendar: 2024-02-29
Market Cap: $ 197,977,678
https://quantum-si.com
Sec Filling | Patents | 115 employees

Quantum-Si Incorporated develops protein sequencing platform. The Company offers semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing.

drug discovery diagnostics semiconductor chip

add to watch list Paper trade email alert is off